EU leaders seek to inject energy into slow vaccine rollout

Thursday, February 25, 2021 | Lorne Cook And Raf Casert, Associated Press

European Council President Charles Michel speaks with Ireland's Prime Minister Micheal Martin, on screen right, via videoconference at the European Council building in Brussels, Wednesday, Feb. 24, 2021. (AP Photo/Olivier Matthys, Pool)

BRUSSELS (AP) — European Union leaders sought to inject new energy and a fresh sense of unity into the bloc’s lagging coronavirus vaccination efforts Thursday as concern mounts that new variants might spread faster than authorities can adapt.

The leaders opened talks via videoconference and debated ways to ease production bottlenecks and speed up the rollout of vaccines, as well as the severity of restrictions that should remain in place to halt the spread of the virus, which has killed more than 531,000 people across the bloc's 27 nations.

Divisions among EU member countries, including Germany, Austria and the Czech Republic, on tight border restrictions to stave off transmission has again raised the specter of travel delays and long traffic backups in a bloc that prides itself on being a seamless market.

“The epidemiological situation remains serious, and the new variants pose additional challenges. We must therefore uphold tight restrictions while stepping up efforts to accelerate the provision of vaccines,” the leaders will say, according to a draft summit statement seen by The Associated Press.

The European Commission has sealed deals with several companies for well over 2 billion vaccine shots — far more than the EU population of around 450 million — but only three have been authorized: jabs from Pfizer-BioNTech, Moderna and AstraZeneca. Officials say the Johnson & Johnson vaccine could be approved next month.

Not far from where European Council President Charles Michel chaired the video summit from Brussels, EU lawmakers grilled the heads of the big pharmaceutical companies.

AstraZeneca CEO Pascal Soriot fielded many questions from the European Parliament, especially after he confirmed that the company would deliver less than half the vaccines it had committed to in the first quarter. The EU has partly blamed supply delays for lagging far behind nations like Israel, the United States and Britain when it comes to vaccinations. By early this week, 6.5% of the adults living in the EU had been vaccinated, compared to more than 27% in the U.K.

Soriot said AstraZeneca would deliver 40 million doses to the EU in the first quarter, attributing the delay to complicated production issues, including “lower than expected output in our dedicated European supply chain."

Moderna CEO Stephane Bancel said production problems are inevitable as companies work around the clock to do in one year what normally takes 3-4 years. Most of the company chiefs said they expect an improvement in the second quarter.

“Every time there is a human error, equipment breaking down...or raw material from one of our suppliers late by a day, you cannot start making the product because it will not be safe, you will not have the right quality,” Bancel said, explaining the technological issues facing producers.

Soriot said a big challenge is to improve yield - the number of doses that can be extracted from a liter of vaccine. He also rejected the idea that companies can simply open new production sites to solve the problem, saying that engineers must spend a lot of time training staff.

“Our teams are absolutely stretched to the maximum. There’s no way they could train any more people,” he said. Soriot insisted that most companies developing vaccines probably face the same constraint.

During their summit, the EU leaders also weighed whether and when to introduce vaccine certificates, which could help smooth a return to air travel and possibly avoid another disastrous summer holiday season, as the tourism industry and broader economies suffer from restrictions.

Southern European countries dependent on tourism, like Greece and Spain, support such a system, but their northern EU partners, like Germany, doubt whether the certificates would work.

“First it must actually be clearly resolved that vaccinated people are no longer infectious,” German Chancellor Angela Merkel said in an interview published Thursday in the daily Frankfurter Allgemeine Zeitung. “As long as the number of those who have been vaccinated is still so much smaller than the number who are waiting for vaccination, the state should not treat the two groups differently.”

Austrian Chancellor Sebastian Kurz said he would prefer a green pass system, similar to Israel’s.

“Those who are vaccinated should have full freedom, but so should those who just had corona and are immune, and all those who take a test and can prove through the test that they are negative,” Kurz told Germany’s Bild tabloid.

Public pressure to relax measures is building. The Netherlands has eased some lockdown measures in what Prime Minister Mark Rutte called a calculated risk to make the year-long crisis “bearable.” Denmark just allowed high school students to partially return to classes.

In Belgium, Jean-Marc Nollet, head of the Greens party that is part of the ruling coalition, openly said he no longer followed his own government’s limits on social contacts because “I am a human being and human contact is something vital.”

But according to the draft statement, the leaders will say that the crisis is far from over, especially as vaccine production lags, and that restrictions on nonessential travel, among other measures, remain valid.

With leaders conscious that the pandemic won't end unless it’s defeated everywhere, summit talks will also touch on getting vaccines to other countries in need, notably in Africa, through the U.N.-backed COVAX program.


Geir Moulson in Berlin contributed to this report.

7 Stocks to Watch When Student Debt Forgiveness Gets Passed

Now that the Biden administration is fully in charge, student debt forgiveness has moved to the front burner. Consider these numbers. There is an estimated $1.7 trillion in student debt. The average student carries approximately $30,000 in student loans.

If $10,000 of student debt were to be canceled, there are estimates that one-third of borrowers (between 15 million to 16.3 million) would become debt-free. Of course, if the number hits $50,000 as some lawmakers are suggesting the impact would even greater.

Putting aside personal thoughts on the wisdom of pursuing this path, it has the potential to unleash a substantial stimulus into the economy.

And as an investor, it’s fair to ask where that money would go. After all, there’s no harm in having investors profit from this stimulus as well.

A counter-argument is that the absence of one monthly payment may not provide enough money to make an impact. However, Senator Elizabeth Warren referred to the effect student loans have in preventing many in the millennial and Gen-Z generations from pursuing big picture life goals such as buying a house, starting a business, or starting a family.

With that in mind, we’ve put together this special presentation that looks at 7 stocks that are likely to benefit if borrowers are set free from the burden of student loans.

View the "7 Stocks to Watch When Student Debt Forgiveness Gets Passed".

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Johnson & Johnson (JNJ)2.7$161.25flat2.51%25.35Buy$180.64
Compare These Stocks  Add These Stocks to My Watchlist 

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.